Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,198 GBX | -0.39% | -0.46% | +15.17% |
10:04am | ASTRAZENECA : UBS reiterates its Sell rating | ZD |
May. 14 | FDA extends review of Ascendis Pharma's hormone disorder therapy | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.17% | 239B | |
+31.37% | 588B | |
-3.37% | 364B | |
+19.19% | 326B | |
+5.11% | 285B | |
+10.02% | 210B | |
-7.03% | 200B | |
+9.83% | 167B | |
-0.54% | 161B | |
+1.04% | 124B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- ASTRAZENECA : DZ Bank sticks Neutral